
IKS Health Q1 FY27 Revenue Up 21% YoY to ₹8,936 Mn
Inventurus Knowledge Solutions Limited (IKS Health) announced strong financial results for Q1 FY27, ending June 30, 2026. Revenue grew 21% year-over-year to ₹8,936 million, with a 12% increase in USD. Profit After Tax (PAT) surged by 28% year-over-year to ₹1,937 million. EBITDA also saw a significant 24% year-over-year increase. The company highlighted its resilient business model, client trust, operational efficiency, and the scalability of its care enablement platform. The recent acquisition of TruBridge was noted as a key milestone to expand capabilities and serve a broader range of healthcare organizations. IKS Health also received several recognitions, including a U.S. patent for its AI-driven Engagement Learning Engine.
Key Highlights
- Q1 FY27 Revenue increased 21% YoY to ₹8,936 Mn.
- Q1 FY27 PAT grew 28% YoY to ₹1,937 Mn.
- EBITDA rose 24% YoY, reaching ₹2,949 Mn.
- Company received a U.S. patent for its AI-driven Engagement Learning Engine.
- Acquisition of TruBridge aims to expand capabilities and market reach.
Price Impact
More from IKS